Welcome to the Anticoagulation Therapy Management Certification Program
offered by the University of Southern Indiana through an unrestricted educational
grant from DuPont Pharma. The ever-changing field of health care continually
affords new opportunities for clinical practice, expanding to include inpatient
and outpatient client management, particularly with antithrombotic therapy.
Anticoagulation management has become a cardinal area of concern for health
providers as they seek to improve anticoagulant control and create solutions
to therapeutic problems associated with this therapy. The potential benefits
of an anticoagulant therapy management service include the following: decreased
number of hospitalizations or utilization of health care resources due to anticoagulant
related complications, higher percentage of patients maintained within therapeutic
range as compared with patients not followed in a clinic, improved patient education
and compliance with therapy, and cost effectiveness of care.
The purpose of this continuing education program is to provide an opportunity for physicians, pharmacists, nurses and other healthcare professionals to increase their knowledge and expertise in managing patients receiving anticoagulation therapy. At the conclusion of the program the participant will be able to:
1. Describe the physiology and pathophysiology of the coagulation system.
2. Discuss the clinical assessment and laboratory monitoring of the patient
receiving anticoagulant therapy.
3. Discuss the indications, dosing, adverse effects, and monitoring of antithrombotic
agents.
4. Formulate effective teaching plans for the patient receiving anticoagulant
therapy.
Describe the administrative/operational components important in providing a quality anticoagulation service.
Successful completion of this program does not indicate expertise in the field of anticoagulation. Clinical experience, demonstrated positive patient outcomes and good clinical judgement coupled with the core content of an anticoagulation course ,such as this USI Anticoagulation Management Course, is necessary to attain competency in the field of anticoagulation management.
Information regarding the National Certification Board of Anticoagulation
Providers national certication exam. can be obtained through the Anticoagulation
Forum. The website for the Anticoagulation Forum is http://www.acforum.org
For delivery of course content, the Anticoagulant Therapy Management Certificate Program utilizes the textbook “Managing Oral Anticoagulation Therapy: Clinical and Operational Guidelines” edited by Jack Ansell MD, Lynn Oertell, MS, RN, C-ANP, and Ann Wittkowsy, PharmD. In addition to the textbook, the program utilizes instructor assignments, web resources, and instructor feedback to augment the teaching process. This instruction method provides you with flexibility in completing assignments and in corresponding with instructors. The program spans a six week period after which students will complete a comprehensive examination.
The Certified Anticoagulation Provider Certification Working Group’s Domains and Objectives provides the theoretical framework for the program. Course content for the Anticoagulant Therapy Management Certificate Program consists of five modules divided into several units that focus on principles of care for the anticoagulant patient. The program includes the following modules and units:
| Introduction | Tips on Taking an Internet Course Study Skills Test Taking |
| Module I | Physiology and Pathophysiology of the Coagulation System
Unit One: Normal Physiology of the Coagulation System |
| Module II | Patient Assessment Unit One: Assessment
and Subjective and Objective Patient Data |
| Module III | Applied Pharmacology and Management of Thromboembolism |
| Module IV | Patient Education Unit One: Assessment and
Planning of Patient Anticoagulation Education |
| Module V | Administrative and Operational Considerations |
| Evaluation Online Exam |
Online Course Evaluation Form To be announced |
NEW! Summary of the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
Each unit outlines the required assignments and dues dates. Assignments can be submitted to instructors through email. You will participate in web conferencing, a type of electronic bulletin board where messages can be posted for other class members to view. This serves the purpose of class discussion as well as sharing ideas and resources related to your field.
Within individual units, you will find the following components:
Overview
Objectives
Assignments
Instructor Provided Information/Outline
Suggested Web Resources
Additional Resources
Study Guide Questions
Case Studies
Sample Test Questions
The National Anticoagulant Advisors Board serve as the program reviewers. In addition to providing current updates with anticoagulant therapy, members of the board will answer your questions through a web conferencing system.
To assist you with the design of thiive online examination will be administered. The guidelines are outlined below:
Examination Procedure: The exam will be available on-line. You will be given a password to access the final exam upon the completion of all modules. Directions will be posted for you to follow.
Upon successful completion of all assignments, a comprehensive examination, and a program evaluation, you will receive a certificate of completion. Nurses will receive 48 contact hours. The University of Southern Indiana has been approved as a provider of continuing education in nursing by the Indiana State Nurses Association (ISNA). ISNA is accredited as an approver of continuing education on nursing by the Commission on Accreditation of the American Nurses Credentialing Center.
Pharmacists will receive 4.0 CEUs or 40 contact hours for completion of this
program. The Pharmacists Education Foundation is approved by the Accreditation
Council for Pharmacy Education as a provider of continuing pharmaceutical education.
ACPE accreditation #120-999-98-H01.
s program, we have developed a study and test-taking review. This review consists of three mini-sessions that will cover the highlights of participating in a Internet program, study skills, and test-taking tips.
After the completion of all modules, a comprehens
In compliance with the conflict of interest policy of the Commission on Continuing Medical education of the American Academy of Family Physicians, the authors and editors disclose financial or personal relationships with pharmaceutical or medical equipment companies that may affect their contribution to the development of the program. Disclosure does not suggest bias, but provides registrants with information relevant to evaluation of program content.
Jack E. Ansel, MD serves on speakers’ bureaus for DuPont Pharma, Boehringer Mannheim, and Rhone-Poulenc Rorer.
Nancy E. Cahill, Esq. is a consultant for Roche Diagnostics and is on the speakers’ bureau for DuPont Pharma.
Thomas M. Hyers, MD is on the speakers’ bureau for DuPont and Rhone-Poulenc Rorer.
Lynn Oertel, MS, C-ANP is on the speakers’ bureau for DuPont Pharma.
Joyce A. Thomas, PharmD is on the speakers’ bureau for Rhone-Poulenc Rorer.
Gerald Wilson, RPh is on the speakers’ bureau for DuPont Pharma and Rhone-Poulenc Rorer.
Ann K. Whittkowsky, PharmD is a consultant for DuPont Pharma and serves and their speakers’ bureau as well. In addition, she has received grant support from Apothecon.
USI Home / Introduction / Course Modules